Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You can "try" to prop up the PPS, which is down badly once again this morning.
My point is with each and every PR released, more new = less progress with this ticker.
Not trying to get in at all. But nice try.
Grain of salt ....
You won't be laughing much longer, the way the PPS is dropping daily.
I've been watching. Learning very little except that the PPS continues to retreat and will continue to do so.
Wasn't 5 years ago ... it was just a couple. So wrong, wrong, WRONG!!
FDA approved the pathway but not the device for human use. The FDA does not approve devices like Radiogel for animal use. It remains to be seen whether vets are going to line up to obtain special licensing to handle and process radioactive material in their clinic practices.
No. In the last FDA submission for humans, AMIC used old and recycled animal test data as part of the submission, one of the reasons why the FDA declined the device for a 2nd time. Perhaps the new test data will be submitted, but human trials which are far more expensive (and expansive) than animal trials will likely be required. The company has no monies to do this, and barely enough to cover ongoing animal testing.
There is movement, but more of the bowel kind.
"This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control."
Enough said.
1) This whole thing was held up because the FDA made RDGL start the approval procedure all over again as a device and not a drug.
Uh, no. FDA twice failed the device for human use because the company submitted recycled test data; and so the company elected to pursue the easier route of treating animals with RadioGel because the FDA would have required human trials as a condition of approval the 3rd go round. On the 2nd submittal word leaked internally and insiders privy to the decline bailed days before it was made official, decimating the stock price and wiping out investors' money.
2) Now that they have almost all the approval they need for animals and not just lab rats, the Chairman who started this has the juice when push comes to shove.
You need to read this:
Carlton Cadwell
Dr. Carlton M. Cadwell is Chairman & Secretary at Advanced Medical Isotope Corp. and President at Cadwell Laboratories, Inc
http://www.4-traders.com/business-leaders/Carlton-M-Cadwell-07ML98-E/biography/
https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=9964133
https://www.cadwell.com
Cadwell has funded this thing almost single-handedly from the get-go, but doubtful he will continue to do so.
Yessir. Thanks for keeping it real, tilltom.
Not now, but perhaps when the company gets their act together, I may.
Well, hasn't happened in many years of opportunity, and they cannot get institutional investors even when they present at begfests.
I was on this train, and then it derailed and became a train wreck.
You're forgetting that the company has to get to the point where they have sufficient monies to complete animal trials, then convince vets to obtain the special licensing to be able to provide these treatments. Then the cost to manufacture in quantity, the marketing costs, etc. Quite a hefty climb for an outfit that has $16 in the bank.
Whatever.
Nope, sorry. Humane to do so. No one would want their pet to suffer.
Different for humans vs. animals.
I have a dog that I love dearly. I have had dogs my entire life. But to the extent she was near her normal lifespan and this happened, even my vet would suggest that I put her down. That would be the ethical and responsible thing to do.
For your two buddies. Not necessarily for most pet owners.
The treatment will be pricey because vets will have to get special licensing to administer the treatments. That, plus cost to manufacture + wholesale distribution markup + vet markup ... and you're talking thousands of dollars. Some pet owners won't mind; many others won't be able to afford it without running up their credit cards. And dogs who contract cancer are generally older dogs with a limited lifespans.
That's the problem right there, zomoney. The price point may end up being so high, the average pet owner without pet insurance won't be able to afford the treatment. This was discussed in length last year on this board. There was somewhat of a consensus opinion at the time that by the time the vets add their margin, complete treatment including follow-up could run in the many thousands of dollars ... especially when one factors in that only a few vets will be licensed to administer a radioactive treatment like RadioGel in their clinics.
Indeed, tilltom. Sells continue to outpace buys by quite a bit. We're already back to where we were almost two weeks ago. Fliptard investors fleeing this POS after making a few shekels along the way, leaving carnage in their wake. Seeing trips soon enough.
Way overvalued. Now that the wrecking crew has left the building, PPS is back to what it was before ... and will continue to slide. Seeing trips in "two more months" ... or less.
I'm laughing at those who criticize Barchart because they don't like what it says about their ticker. LMAO!
https://www.barchart.com/stocks/quotes/RDGL/opinion
RDGL still in the sh***er.
That is of course your opinion. Doesn't change how people use this information or the ticker eval.
Okay, then let's look at this respected charting site:
http://www.stockta.com/cgi-bin/analysis.pl?symb=RDGL&cobrand=&mode=stock
Just as bad. Anyone want to criticize StockTA? I could do this all day. RDGL's performance or lack thereof speaks for itself.
I don't have to name anyone. Barchart is a very popular and respected charting website ... unless your ticker is failing and getting poor marks.
A great many seasoned investors do. LMFAO!
Wow. Not looking good here.
https://www.barchart.com/stocks/quotes/RDGL/opinion
Absolutely love this post of yours, Homebrew. Couldn't have said it better myself ... "lemonade stand cancer cure" is "running out of juice."
Perfect!
I agree.
I don't have PM, but to answer your question, no PPS.
This is sitting at .005 right now. Do you honestly believe that absent an R/S, the PPS will hit .10 in a few days?? It's back to a downward trend now that the fliptards are selling off.
With a reverse split, maybe. Otherwise a pipe dream.
Not bashing at all. Calling it like I see it, just like you're doing the same. I'll "switch up" when I see actual progress being made by the company, and the promise of institutional funding. As of now, it's just a dumpster fire being propped up by flip trading.
Many will end up being bagholders. It's abundantly clear that this ticker was doing nothing the past several months, except to trend downward on low volume. Then a new wrecking crew came in about a week or two ago to drive up the PPS, then sell off the next few days to lock in their flip trade shekels.
Wash. Rinse. Repeat.
Once volume dies back down - and it always does following something like this - it's headed back to the dust bin of sticky pinky oblivion.
Again, 3 years ago. Much has changed since then, none of it positive. Just look at the action here. PPS sliding back to where it was prior to last week, and continuing to decline every day.
So what does this get you? Go find vets who are authorized to handle radioactive devices. And the cost per treatment is going to be high, by the time it is marked up.
3 years ago, when there was actually some optimism on this board. Now a new crew comes in to P&D this ticker to death.